Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 7Colorectal Neoplasms 5Head and Neck Neoplasms 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Radiation Injuries 2Neoplasm, Residual 2Esthesioneuroblastoma, Olfactory 2Depression 2Colonic Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Skin Abnormalities 1Sarcopenia 1Sarcoglycanopathies 1Resectable Pancreatic Cancer 1Recurrence 1Postoperative Complications 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Ototoxicity 1Neoplastic Cells, Circulating 1Malnutrition 1Lymphatic Metastasis 1Liver Neoplasms 1

Interventions

Vincristine 1Surveys and Questionnaires 1Radiotherapy 1Radiosurgery 1Methotrexate 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1Genetic Association Studies 1Drug Therapy 1Cyclophosphamide 1Cisplatin 1Chemotherapy, Adjuvant 1Chemoradiotherapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Ototoxicity × Chemotherapy, Adjuvant × Clear all
NCT00683319 2013-09-20

Observing Young Patients With Ependymoma Undergoing Standard Combination Chemotherapy

National Cancer Institute (NCI)

Active not recruiting
50 enrolled
CNS

Ototoxicity, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡